Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
7.14
+0.62 (9.51%)
At close: Mar 9, 2026, 4:00 PM EDT
7.05
-0.09 (-1.26%)
Pre-market: Mar 10, 2026, 9:09 AM EDT

Edesa Biotech Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-7.82-7.19-6.17-8.37-17.55-13.34
Depreciation & Amortization
0.10.120.190.180.120.12
Stock-Based Compensation
1.050.730.541.252.263.2
Other Adjustments
---0.01---
Change in Receivables
-0.06-0.380.360.562.03-3.23
Changes in Accounts Payable
-1.07-0.720.02-0.560.88-0.12
Changes in Other Operating Activities
-0.090.110.20.3-0.02-0.28
Operating Cash Flow
-7.89-7.32-4.89-6.64-12.28-13.66
Capital Expenditures
-----0.01-0.01
Investing Cash Flow
-----0.01-0.01
Long-Term Debt Repaid
---0.03---
Net Long-Term Debt Issued (Repaid)
---0.03---
Issuance of Common Stock
7.587.720.735.1211.9614.36
Net Common Stock Issued (Repurchased)
7.587.720.735.1211.9614.36
Issuance of Preferred Stock
4.949.88----
Net Preferred Stock Issued (Repurchased)
4.949.88----
Other Financing Activities
-0.46-0.57-0.11-0.29-0.33-0.19
Financing Cash Flow
18.4117.030.594.8311.6314.17
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.070.05-0.030.08-0.090.12
Net Cash Flow
10.499.75-4.32-1.73-0.750.63
Free Cash Flow
-7.89-7.32-4.89-6.64-12.28-13.67
FCF Margin
-1348.84%-934.09%-700.32%-1142.18%-1574.48%-132.20%
Free Cash Flow Per Share
-----5.34-7.86
Levered Free Cash Flow
-8.88-7.67-5.8-8.45-16.57-13.64
Unlevered Free Cash Flow
-9.42-8.4-6.61-9.29-17.4-23.98
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q